NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Other Non-Current Assets of $106000.0 in Q1 2026, down 6.19% quarter-over-quarter from $113000.0 in Q4 2025, and down 13.11% on a YoY basis from $122000.0 in Q1 2025.
NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $106000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 13.11% year-over-year to $106000.0; the TTM figure through Mar 2026 stood at $106000.0 (down 13.11% YoY), while the FY2025 annual figure was $113000.0, up 653.33% from the prior year.
- Other Non-Current Assets was $106000.0 for Q1 2026 at NeuroPace, down from $113000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $300000.0 in Q4 2022 to a low of $15000.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $122529.4 across 5 years, with a median of $122000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 87.7% in 2024, then jumped 653.33% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $300000.0 in 2022, then tumbled by 59.33% to $122000.0 in 2023, then sank by 87.7% to $15000.0 in 2024, then surged by 653.33% to $113000.0 in 2025, then decreased by 6.19% to $106000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $106000.0 (Q1 2026), $113000.0 (Q4 2025), and $120000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Sep 30, 2021 | 122,000.00 |
| Jun 30, 2021 | 122,000.00 |
| Mar 31, 2021 | 366,000.00 |